Chargement en cours...

Novel Strategies to Improve the Endocrine Therapy of Breast Cancer

Endocrine therapy (ET) constitutes the usual first-line of therapy for patients in the treatment of metastatic hormone receptor-positive breast cancer. Unfortunately, not all patients respond to first-line endocrine treatment due to intrinsic resistance, while others may initially respond but eventu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncol Rev
Auteur principal: Castrellon, Aurelio Bartolome
Format: Artigo
Langue:Inglês
Publié: PAGEPress Publications, Pavia, Italy 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444409/
https://ncbi.nlm.nih.gov/pubmed/28584571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/oncol.2017.323
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!